Oral cancer is one of the most common cancers, 1 and the survival rate of patients with oral cancer has not improved despite improvements and innovations in diagnostic techniques and treatments. 2 It is thought that most, if not all, cases of oral squamous cell carcinoma (OSCC) are preceded by a period during which the affected epithelium shows evidence of epithelial dysplasia, although this may not always be clinically apparent. 3 Histological criteria to assess cellular and tissue changes (dysplasia) have been defined by the World Health Organization 4 and are related to alterations in the kinetics of cellular proliferation and the maturation of the epithelium. 5 A better understanding of the molecular mechanisms underlying the development of OSCC may add to the treatment and prognosis of this disease.
The Notch signaling pathway has an important role in cellular patterning and differentiation during development. 6 Notch signaling has been highly conserved through the evolution from worm to man. Mammals have four Notch receptors (Notch1-4) that are transmembrane receptors harboring an extracellular domain responsible for the binding of their specific ligands and an intracellular domain involved in transcriptional regulation. Notch receptors can receive signals from neighboring cells that express transmembrane-type ligands such as Delta-like ligand and Jagged (JAG). 7 Ligand binding to Notch receptors leads to the activation of common intracellular signaling pathways, which results in the cleavage of the intracellular Notch domain (NICD). NICD translocates into the nucleus and heterodimerizes with CSL/CBF-1/RBP-Jk. The CSL/CBF-1/RBP-Jk-NICD complex is activated by the Mastermind family of coactivators and transactivates target genes such as mammalian hairly enhancer of split (Hes) and Hey family members. 8 The association between Notch1 signaling and tumorigenesis was first noted in a subset of T-cell acute lymphoblastic leukemia (T-ALL). 9 The gain-of-function mutations in areas of Notch1 heterodimerization may partially account for the incidence of ALL cases exhibiting increased Notch pathway activity. Recent studies have also identified activated Notch1 mutations in chronic lymphocytic leukemia. 10 The dysregulated expression of Notch receptors, ligands and targets is also observed in solid tumors, including lung, pancreatic, cervical and prostate carcinomas. [11] [12] [13] [14] High-level expressions of Notch1 and JAG1 are associated with poor prognoses in patients with breast cancer or metastasis of prostate cancer. 15, 16 On the other hand, there is growing evidence that Notch signaling activation may have growthsuppressive functions in other hematopoietic cells, hepatocytes, the pancreatic epithelium and skin. [17] [18] [19] [20] Several studies have indicated that upregulation of Notch signaling may contribute to the malignant phenotype in head and neck squamous cell carcinomas (HNSCCs), including those of the oral cavity. 21, 22 However, some researchers have shown that Notch signaling has a tumor suppressive role. 23, 24 To resolve the discrepancies between the reported roles of Notch signaling in OSCCs, the precise knowledge of the expression of Notch in normal and cancerous lesions of the oral cavity is crucial.
To better understand the role of the Notch pathway in oral carcinogenesis, we first examined immunohistochemical staining patterns of Notch1, NICD and JAG1 in normal epithelium, premalignant lesions (dysplasia) and cancer tissue of the oral cavity. We confirmed the presence of similar patterns using immunohistochemical staining in a rat carcinogenesis model. Next, we examined the expression of Notch signaling-related molecules in OSCC cell lines. Based on the results of the reinvestigation of the localization of Notch1 and NICD immunoreactions, we focused on the relationship between Notch1 expression and tumor invasion, especially inflammation-related tumor invasiveness. To clarify the involvement of Notch1 in the proliferation and TNF-a-dependent activation of tumor invasion, we used Notch1-specific small interfering RNA (siRNA) to knockdown the Notch1 gene in an OSCC cell line. Finally, we examined the effects of Notch pathway inhibition by the g-secretase inhibitor (GSI), a pharmacological agent known to effectively block Notch activation, on the proliferation and TNF-a-dependent invasiveness of OSCC cell lines.
MATERIALS AND METHODS Patients and Tissue Specimens
Tissue samples of OSCC (n ¼ 12), dysplasia (n ¼ 36) and adjacent normal mucosa (n ¼ 12) were obtained from 50 patients and used for the following studies. The samples were fixed with 10% formalin (fixation duration was up to 1 week) and embedded in paraffin. The tissues sections were stained with hematoxylin and eosin. A histological diagnosis of the samples was made according to the criteria of the World Health Organization. 4 Additional sections were used for immunohistochemical staining.
For the clinicopathologic analysis, primary oral cancer tissue samples were obtained from 54 patients with advanced OSCC treated at Kumamoto University Hospital between October 2003 and January 2009. All patients were preoperatively treated with chemoradiotherapy. Radiotherapy was administered at a daily dose of 2.0 Gy five times a week for 15 days. An oral fluorouracil anticancer agent, S-1, was concurrently administered at a dose of 80, 100 or 120 mg per day according to each patient's body surface area for 14 days after the initiation of radiotherapy. All tumors were staged according to the TNM classification of the UICC (2002), and the degree of differentiation was determined according to the grade classification of the WHO. The study followed the guidelines of the Ethics Committee of Kumamoto University. The nature and aims of the study were explained to all patients, who gave their informed consent for the research.
Animals, Carcinogens and Tissue Specimens
Rat lingual tissues containing normal, dysplastic and cancerous lesions were prepared as described previously. 25 Briefly, male F344 rats were exposed to either control water or water-containing 4-nitroquinoline 1-oxide (4-NQO) for at least 28 weeks. Then, the rats were killed and lingual tissue specimens were obtained. A total of 15 paraffin sections (of normal epithelium, dysplastic tissue and tissue of invasive carcinoma, n ¼ 5 for each group) were used for immunohistochemical staining. Animals were handled in accordance with the animal care policy of Kanazawa Medical University.
Immunohistochemical Staining and Evaluation
Formalin-fixed, paraffin-embedded (FFPE) specimens were cut into 4-mm sections and mounted on MAS-GP-coated slides (Matsunami Glass Ind., Osaka, Japan). After being deparaffinized and rehydrated, the sections were heated using an autoclave in 1 mM EDTA and Tris/HCl buffer (pH 9.0) (for Notch1) or 0.01 mol/l citrate buffer (pH 7.0) (for JAG1 and NICD) for antigen retrieval. The sections were incubated with 0.3% H 2 O 2 in absolute methanol for 30 min to block endogenous peroxidase activity. Then, the sections were incubated with Protein Block Serum Free Reagent (Dako, Glostrup, Denmark) for 15 min to block nonspecific staining. After the blocking step was completed, the sections were incubated with antibodies against Notch1 (D1E11; Cell Signaling Technology, Danvers, MA, USA), JAG1 (Epitomics, CA, USA) or NICD (Val1744 Rabbit mAb; Cell Signaling Technology) at 4 1C overnight. This was followed by sequential 60-min incubations with the secondary antibodies (En Vision þ System-HRP-Labeled Polymer; Dako) and visualization with the Liquid DAB þ Substrate Choromogen System (Dako). All slides were counterstained with hematoxylin for 30 s before being dehydrated and mounted. The results for Notch1 and JAG1 were considered positive when 0 -CTCCTTAATGTCACGCACGATTTC-3 0 ). The PCR products were analyzed using agarose gel electrophoresis and visualized using staining with ethidium bromide.
For quantitative real-time PCR (qRT-PCR), each reaction mixture was diluted fivefold with DNase/RNase-free water (Invitrogen), and 4 ml of each mixture were subjected to PCR. The reactions were run using THUNDERBIRD SYBR qPCR Mix (Toyobo, Osaka, Japan) on a Light Cycler 1.5 (Roche, Indianapolis, IN, USA). The comparative Ct (DDCt) method was used to determine fold changes in expression using glyceraldehyde-3-phosphate dehydrogenase (GAPDH). Each sample was run in triplicate. The following primers were used: Snail (forward: 
Immunofluorescence Microscopy
The cells were fixed in 4% paraformaldehyde in a phosphatebuffered saline (PBS) solution for 30 min. After fixation was completed, the cells were centrifuged at 2500 r.p.m. for 10 to 15 min. The supernatant was poured off and the cell pellets were embedded in paraffin blocks. Microtome was used to section the blocks of FFPE cells into 4-mm-thick sections. The sections were then transferred to glass slides. The slides were deparaffinized before being analyzed. After being blocked with Protein Block Serum-Free Reagent (Dako) for 30 min, the primary antibodies were diluted in Dako Real TM Antibody Reagent (Dako). After being incubated for 24 h with the antibodies and subsequently washed with PBS three times Transfection with siRNA SAS cells were used in this experiment. Twenty-four hours before siRNA transfection was performed, the cells were diluted in fresh medium without antibiotics and transferred to 60-mm dishes (Nunc, Waltham, MA, USA). The cells were grown and transfected with Notch1-specific siRNA and Stealth TM RNAi Universal negative control (Sthealth siRNA, 40 nM; Invitrogen) using Lipofectamine RNAi MAX (Invitrogen), as per the manufacturer's instructions. The sequences for siRNA were as follows: for Notch1, sense strand 5 0 -UCGCAUUGACCAUUCAACUGGUGG-3 0 , antisense strand 5 0 -CCACCAGUUUGAAUGGUCAAU-3 0 . The cells were harvested 48 h post-transfection for western blotting.
GSI Treatment
SAS cells were seeded 24 h before the treatment was started. Then, InSolution TM GSI (Calbiochem, Darmstadt, Germany) was added at a final concentration of 5 or 10 mM. An equal amount of dimethyl sulfoxide (DMSO; Wako, Osaka, Japan) was used as the control for GSI.
Cell Proliferation Analysis
Cell proliferation was determined using the cell proliferation reagent WST-8 (Cell Counting Kit-8; Dojindo, Kumamoto, Japan). Briefly, 2 Â 10 3 cells were seeded into 96-well plates in 100 ml of the medium in quadruplicate for each condition. At 24 and 48 h, WST-8 reagent was added to each well at a 1:10 dilution and the plates were incubated for an additional 3 hours at 37 1C. Sample absorbance was measured at 690/ 480 nm. Each experiment was performed in triplicate.
Matrigel Cell Invasion Assay
Cell invasion activity was measured with the BioCoat Matrigel Invasion Chamber (Becton Dickinson, Tokyo, Japan) according to the manufacturer's protocol. OSCC cells transfected with or without Notch1 siRNA were inoculated on the coated Matrigel of the culture inserts (upper chamber) at a density of 2 Â 10 5 cells per 500 ml of serum-free DMEM. TNF-a (5 ng/ml; R&D Systems, Abingdon, UK) was then added to the culture insert (upper chamber) and incubated for 24 h at 37 1C and a 5% CO 2 atmosphere. At the end of the incubation, the cells on the upper surface of the filter were completely removed with cotton swabs. The invaded cells that remained on the lower surface of the filter were fixed with methanol and stained with Diff-Quick (Sysmex, Hyogo, Japan). The numbers of stained cells in five randomly selected microscopic fields ( Â 200) per filter were counted. The experiments were repeated at least three separate times to confirm reproducibility. In these experiments, the inserts harboring type 1 collagen-coated filter (CytoSelectt 24-Well Cell Invasion Assay, Collagen I; Cell Biolabs, San Diego, CA, USA) were used in control experiment. Briefly, 2 Â 10 5 cells per 300 ml of serum-starved SAS cells were added to the upper polycarbonate membrane insert (8-mm pore size) of the cell migration assay kit in a 24-well plate. Then, TNF-a (5 ng/ml; R&D Systems) was then added to the upper insert. In the lower well, 500 ml DMEM with 10% FBS was used as a chemoattractant. After 24 h of incubation, migratory cells were stained, photographed and quantitated by absorption at 560 nm.By using two types of filters in our preliminary experiment, the behavior of cells in TNF-a-treated condition was confirmed to be similar, regardless of the matrix used in the filter.
Statistical Analysis
The differences in mean values between two groups were statistically analyzed using Student's t-test or the MannWhitney U-test, whereas the differences in mean values between multiple groups were analyzed using one-way ANOVA with the Bonferroni/Dunn test. For the analysis of Notch1 and NICD expressions in the tissue specimens, the w 2 -test was used to determine the association between Notch1 and NICD. Fisher's exact test was used when one or more cells had expected values o5. All P-values were based on two-tailed statistical analyses, and P-values o0.05 were considered to be statistically significant (*Po0.05 and **Po0.01). All statistical analyses were completed using the JMP 9 software program (SAS Institute, Cary, NC, USA).
RESULTS

Immunohistochemical Staining Patterns Indicate that Notch1 Signaling is Involved in the Formation of OSCC
To determine the association between the expression of Notch1 signaling-related molecules and oral carcinogenesis, an analysis of the expression of these molecules was conducted using immunohistochemical staining. Tissue specimens containing 60 oral lesions and adjacent normal mucosa from 50 patients with dysplasia or OSCC (as described in patients and tissue specimens) were evaluated for the expression of Notch1, NICD and JAG1. All examined specimens were scored according to the criteria described in Materials and Methods. In most of the normal oral mucosal tissues, the immunoreactions for Notch1 were scanty and confined nonspecific reactions were observed in the basal and parabasal compartments (Figure 1aD ). In the dysplastic tissues, the dysplastic cells showed immunoreactions for Notch1 that were weak or moderate in intensity, and the numbers of Notch1-positive cells were slightly increased (Figure 1aE ). In the cancerous tissues, the majority of OSCC cells showed strong immunoreactions for Notch1 (Figure 1aF ). The staining patterns of Notch1 was membranous, whereas that of NICD was nuclear (Figures 1aG-I) . The immunoreactions of NICD tended to increase in both (Table 1 ; P-value o0.01). Moreover, JAG1 showed similar results and exhibited the highest expression in the OSCC tissues (see Supplementary Figure S1 ).
To confirm the results obtained from the human specimens, we investigated the changes in Notch1 and NICD expressions in rat tongue tissues containing various pathological grades. In this experiment, normal epithelium (n ¼ 5) and tissues of dysplasia (n ¼ 5) and invasive OSCC (n ¼ 5) were examined for Notch1and NICD immunostaining. Similar to the results of the human specimens, the staining intensity and numbers of Notch1-positive cells increased in the tissues in the following order: normal epithelium, dysplastic tissues and cancerous tissues. The similar tendency was observed in immunostaining pattern of NICD (Figures 2a-i ).
Notch1 and Related Molecules are Expressed in OSCC Cell Lines
To determine whether Notch1/NICD-and Notch1 signalingrelated molecules are expressed in cultured OSCC cell lines (HSC-2, HSC-3, SAS, Ca9-22, KN, OSC-20, OSC-19 and HOC-313), the cell lysates were analyzed using western blotting and RT-PCR. Using RT-PCR, mRNAs of Notch1-and Notch1 signaling-related molecules were detected in almost all of the cell lines (Figure 3a) . In immunofluorescence staining, Notch1, NICD, JAG1, Hes1 and Hey1 were also clearly detectable in in SAS cells (Figure 3b ). In addition, the NICD expression was enhanced when the cells were treated with human recombinant JAG1 in our preliminary experiment (see Supplementary Figure S2 ). These results demonstrate that the genes and proteins of Notch1 and related molecules are expressed in OSCC-derived cells and signaling is activated in OSCC cell lines as a result of the nuclear expression of NICD.
Generally, NICD expressions reflect the activation status of Notch signaling. Based on the results of RT-PCR, western blotting, immunofluorescence staining and JAG1 treatment, SAS cells were regarded as one of the typical Notch1-expressing OSCC cell lines. Therefore, SAS cells were used in following experiments in this study.
Clinical Significance of Notch1 in OSCC Tissues
Because increased Notch1 expression was observed in cancerous tissues and Notch1 signaling molecules were detected in the majority of OSCC cell lines, the clinical significance of Notch1 in human OSCC was examined using immunohistochemical staining. Tissues obtained from 54 patients with OSCC were evaluated for the expression of Notch1. The clinicopathologic details of the patients are shown in Table 2 . Although no differences were observed in the expression status of Notch1 with respect to age, gender, primary tumor site or differentiation, the Notch1 expression was found to be positively correlated with T-stage and clinical stage (Po0.05), as determined by the w 2 -test. These results indicate that increased expression of Notch1 may correlate with OSCC progression.
Notch1 Knockdown Inhibits the Proliferation of OSCC Cells
To determine whether Notch1 expression affects the growth of OSCC cells, we examined the proliferation of SAS cells after treatment with Notch1 siRNA. The Notch1 siRNAtreated SAS cells exhibited a significant reduction in cell proliferation compared with the cells treated with negative control siRNA (Figure 4a ; P-value o0.05). A microscopic examination confirmed that the number of cells was markedly decreased (Figure 4b ). Based on the results of Notch1 knockdown experiments, we explored the possibility of alteration in signal-transduction pathway, such as Akt, MAPK and Stat3 pathway by using western blotting analysis. In addition, we also confirmed the reduction of proliferation activity by using p-H3, one of the mitosis-associated molecules. Western blotting showed that the expressions of Notch1, NICD, Hes1 and p-H3, a mitosis-associated marker, were significantly reduced under Notch1 siRNAtransfected conditions. Moreover, a reduction in the level of p-Akt was observed under the same conditions (Figure 4c ), although no remarkable changes in the levels of MAPK or Stat3 occurred (data not shown). From these results, we concluded that Notch1 has an important role, and Akt signaling could be involved in the proliferation of cultured OSCC cells. Fisher's exact test was used to examine the relationship between the Notch1 and NICD expressions in the tissue specimens. **Po0.01.
TNF a-Dependent OSCC Cell Invasiveness
To determine the significance of Notch1 expression other than proliferation, we further analyzed the expression pattern of Notch1 in the histological samples. In the OSCC specimens, Notch1 was primarily expressed in the cells at the epithelial-stromal interface (Supplementary Figure S3A) . Furthermore, NICD was strongly expressed in the cells at the invasive tumor front (Supplementary Figure S3B) .
Based on the localizations of Notch1 and NICD observed in the histological analysis, we hypothesized that Notch1 signaling could be involved in the invasiveness of OSCC cells. Therefore, a Matrigel invasion assay was completed to assess whether the Notch1 expression affects the invasiveness of OSCC cells in vitro. In this experiment, TNF-a, a well-known accelerator of tumor invasion, was used. TNF-a has been reported to show an increased expression in OSCC specimens 27 and promote S2 cleavage (resulting in NICD Notch1 in oral squamous cell carcinoma R Yoshida et al production) via TACE maturation in Notch signaling. [28] [29] [30] As shown in Figure 5 , NICD cleavages were observed in a TNF-a concentration-dependent manner. In addition, NICD cleavage was inhibited by GSI treatment. Our results indicate the existence of activation mechanisms of Notch signaling by TNF-a, and the potential utility of GSI for Notch signaling activation by TNF-a. Indeed, in the control siRNA-transfected SAS cells, TNF-a markedly activated the invasive properties of the cells (Figures 6a and b) . The activation of tumor cell invasion was observed in the experiment using type 1 collagen-coated filter (Supplementary Figure 4S) and also in the experiment using Matrigel-coated filter. Therefore, in the following experiments, we used SAS cells treated with TNF-a in the Matrigel as a control for the experiments of Notch1 inhibition. In contrast, TNF-a-dependent activation of tumor invasion was significantly inhibited under Notch1 knockdown conditions (Figures 6c and d) . To identify the mechanism underlying this phenomenon, we explored changes in related molecules using western blotting and quantitative real-time PCR. No significant changes were observed in the Stat3, MAPK or Akt pathways or in the expressions of matrix metalloproteinase (MMP)-2 or -9 (data not shown). However, mRNAs of Slug and Twist, critical transcriptional factors that control cell invasion, 31 were affected by TNF-a treatment and decreased significantly under Notch1 knockdown conditions (see Supplementary  Figures S5A-C) . These results suggest that Notch1 may contribute in part to TNF-a-dependent OSCC cell invasion via the transcriptional regulation of Slug and Twist.
GSI Inhibits the Proliferation, Migration and Invasion of OSCC Cells
To test the possible application of GSI in the treatment of OSCC, SAS cells were treated with GSI or a control vehicle (DMSO) and cell proliferation, migration and invasiveness were assessed. As shown in Figure 7a , GSI significantly inhibited cell proliferation in a dose-dependent manner (Po0.05). Using western blotting, decreased expressions of NICD, Hes1, p-H3 and p-Akt were confirmed. Furthermore, the number of invaded cells enhanced by TNF-a was significantly decreased under the GSI treatment conditions (Figure 7c ; P-value o0.01). These results suggest that GSI has a potential for clinical use in OSCC treatment.
DISCUSSION
Notch1 and its signaling have been examined in various types of cancer. Although the oncogenic role of Notch signaling in T-ALL is well established, 32 a common theme for the role of Notch signaling in tumorigenesis remains elusive. In many types of solid tumor, including cancers of the lung, 11 breast, 16 pancreas 13 and prostate. 14 Notch1 signaling therefore seems to have a crucial role. Notch1 signaling also appears to have tumor suppressor roles in murine keratinocytes, 20 human pancreatic 19 and hepatocellular carcinomas 18 and small-cell lung cancer. 33 Taken together, these observations indicate that aberrant activation of the Notch1 pathway has various roles in solid tumors. Moreover, the cellular reactions and outcomes of the overexpression of Notch1 activity are highly dependent on contextual cues such as interactions with the tumor microenvironment and crosstalk with other signaling pathways. Our present report provides an extensive evaluation of Notch1 expression in human OSCC tissues and the effects of Notch1 expression in OSCC cell lines.
Strong Notch1 expression was seen in the cell membrane of oral cancer cells in our present study, whereas a weak and limited expression was observed in the basal layer in normal tissues. In previous studies, the overexpression of Notch1 and its ligands has been observed in OSCC specimens. 34, 35 However, a recent study demonstrated opposite results to this study. The study of Sakamoto et al 24 showed similar Notch1 expression to that observed in our study in normal tissues, whereas their results for dysplastic and cancerous tissues were different, and Notch1 was downregulated in the neoplastic lesions.Although the antibodies against Notch1 and staining method used in our study were different from those used by Sakamoto et al, 24 our immunohistochemical staining results showed clear and specific membranous The w 2 -test was used to examine the relationship between the Notch1 expression and the clinicopathologic factors. *Po0.05; **Po0.01. Fisher's exact test was used when one or more cells had expected values o5.
staining. In our study, NICD was similarly detected by immunohistochemistry in Notch1-positive cells, which supports that our Notch1 immunohistochemical results were reliable. Moreover, the present study demonstrated that many human OSCC lines had Notch1 protein and mRNA, which also supports that many surgically resected OSCC tissues are In our clinicopathological analysis, a high level of Notch1 expression was found to be correlated with both T-stage and clinical stage in patients with OSCC. Although a statistical correlation was not observed, an increasing percentage of patients with Notch1-positive cancers showed advanced Nodal status. These results indicate that Notch1 has a potential role in OSCC progression. In addition, similar to our present study, two reports have described the clinical significance of Notch1 expression in HNSCCs, including OSCC. 36, 37 Therefore, we concluded that Notch1 may have an important role in OSCC progression.
Based on the histological findings observed in the human and rat OSCC samples, we hypothesized that Notch1 regulates the proliferation and invasiveness of OSCC cells. This was confirmed in vitro. First, we examined the expressions of Notch1, its related molecules and NICD, which indicates the activation of Notch1 signaling, in a panel of OSCC cell lines. Second, we investigated whether the Notch1 expression affects the proliferation of cultured OSCC cells using Notch1-specific siRNA and a WST assay, as the importance of the Notch1 expression for cell proliferation is well known and has been previously examined. [38] [39] [40] Most of OSCC cell lines expressed Notch1 signaling molecules and NICD, and Notch1 knockdown significantly inhibited cell proliferation activity. Although it has also been suggested that downregulation of the Notch1 pathway induces the suppression of cell proliferation in OSCCs, 34 the mechanisms underlying this phenomenon are not well understood. In our present data, the phosphorylation of Akt was downregulated by the inhibition of Notch signaling, which suggests that the Notch1 expression affects the proliferation of cultured OSCC cell lines via Akt signaling. In OSCC, Akt signaling has an important role in its progression, 41, 42 and inhibition of Akt signaling suppresses malignant phenotype. 43 Recently, growing evidence has indicated a relationship between Notch signaling and tumor cell invasion. 44, 45 Our present data demonstrated that the Notch1 expression influences the TNF-a-dependent invasiveness of OSCC cells via the transcriptional regulation of Slug and Twist, important regulators of cell invasion. 31 Several reports have described the significance of Notch signaling for the invasiveness of squamous cell carcinomas, including those of the oral cavity. In these reports, MMPs, the nuclear factor-kB pathway and micro-RNAs were reported to be associated with increases in invasive phenotypes. 46, 47 Our data support these previous findings and we conclude that Notch1 has a role in a certain type of OSCC invasion. However, we need further investigation to determine what mechanisms underlie the invasiveness of OSCC cells because Notch signaling shows cross-talk with many other pathways and regulates the properties of these pathways based on complicated mechanisms.
GSI prevents the activation of Notch signaling, and several Notch inhibitors have been tested for antitumor effects. 48 Our present data clearly demonstrated that treatment of OSCC cells with GSI effectively reduces the NICD/Hes1 protein expression and prevents growth in OSCC cell lines, similar to that observed in Notch1 knockdown conditions. In our study, GSI treatment inhibited not only cell proliferation but also OSCC cell migration and invasion. Similar effects of GSI on the migration and invasion of cancer cells has been reported in pancreatic cancer and melanoma. 49, 50 These findings suggest that GSI effectively inhibits the Notch pathway in OSCC cell lines and that the progression of OSCC is regulated by this signaling system. Recently, another effect of GSI on the drug resistance phenotype of cancer cells in Notch signaling was reported. 51, 52 Therefore, further study is required to determine the biological significance and antitumor effects of GSI in OSCC.
In conclusion, we demonstrated that the Notch1 expression is involved in the maintenance of the proliferation and TNF-a-dependent invasiveness of OSCC cells. Although the use of a single cell line in functional analysis is a limitation of this study, the expressions of NICD, which indicates activation of Notch signaling, in majority of OSCC cell lines and OSCC specimens were confirmed. Moreover, positive correlation between the expressions of Notch1 and NICD was observed in immunohistochemical analysis. Therefore, the activation of Notch signaling may occur in the other cell lines and clinical OSCC. Indeed, one report has demonstrated the tumor suppressor functions of Notch signaling based on the findings of loss-of-function mutations of Notch1 in HNSCC. 53 However, in that report, this type of mutation was detected in a certain subset of patients having HNSCC. Therefore, considering the previous studies of HNSCCs, 34, 46 including OSCC that indicate the oncogenic functions of Notch1 and the context dependency of Notch signaling, certain types of OSCC cells may require Notch1 expression for progression. Moreover, GSI, a pharmacological agent known to effectively block Notch1 activation, was found to inhibit the proliferation, migration and invasiveness of OSCC cells, which suggests the potential for using GSI in OSCC treatment.
